Epstein-Barr Virus Latency as a Stress Test of Aging Immune Surveillance
Current understanding
Lifelong EBV persistence in >90% of adults is reframed as a continuous functional probe of aging immune competence: age-related erosion of EBV-specific CD8 T-cell containment, NK surveillance, and tissue immune ecology permits reactivation, hyperinflammation, lymphoproliferation, and EBV-associated malignancy, with chronic active EBV disease and post-transplant lymphoproliferative disease sitting at the severe end of the spectrum [expert-opinion, review-level synthesis]. Mechanistic links to immunosenescence (CD8 exhaustion, inflationary memory, NK decline) and inflammaging (chronic antigenic drive, cytokine tone) are inferred from converging prior literature rather than new primary data. Human-translation status: the integrative framing is clinically grounded in known EBV syndromes but has not been operationalized into measurable ‘EBV immune-surveillance age’ metrics or interventions.
Evidence log
- 2026-09-30 — Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy.: cross-connection with cellular-senescence: EBV reactivation and EBV-driven lymphoproliferation are framed as consequences of failed surveillance that overlaps with the failed-clearance narrative applied to senescent cells, suggesting shared age-related effector deficits. (novelty: 3)